Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

Below are the top diagnostic substances stocks on the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at

is 33.60 percent. SurModics' PEG ratio is 2.06. The trailing-twelve-month operating margin at

is 27.60 percent. Meridian Bioscience's revenue for the same period is $193.50 million. The trailing-twelve-month operating margin at

is 22.30 percent. AMAG Pharmaceuticals' EPS for the same period is $4.40. The trailing-twelve-month operating margin at

is 18.20 percent. Neogen's ROE for the same period is 9.80 percent.